| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1005946668 |
| P356 | DOI | 10.1385/BTER:83:3:207 |
| P698 | PubMed publication ID | 11794513 |
| P2093 | author name string | Anderson RA | |
| Waters RS | |||
| Bryden NA | |||
| Patterson KY | |||
| Veillon C | |||
| P433 | issue | 3 | |
| P921 | main subject | magnesium | Q660 |
| cobalt | Q740 | ||
| P304 | page(s) | 207-221 | |
| P577 | publication date | 2001-12-01 | |
| P1433 | published in | Biological Trace Element Research | Q15716661 |
| P1476 | title | EDTA chelation effects on urinary losses of cadmium, calcium, chromium, cobalt, copper, lead, magnesium, and zinc | |
| P478 | volume | 83 |
| Q94563279 | A co-formulation of supramolecularly stabilized insulin and pramlintide enhances mealtime glucagon suppression in diabetic pigs |
| Q83951305 | A microfluidic device for separating erythrocytes polluted by lead (II) from a continuous bloodstream flow |
| Q28384540 | Cadmium toxicity and treatment |
| Q53113382 | Changes in blood and urinary cadmium levels and bone mineral density according to osteoporosis medication in individuals with an increased cadmium body burden. |
| Q34124558 | Chelation therapy and cardiovascular disease: connecting scientific silos to benefit cardiac patients |
| Q39361634 | Chelation therapy in cardiovascular disease: an update |
| Q88915669 | Chelation therapy to prevent diabetes-associated cardiovascular events |
| Q28393954 | Chelation therapy to treat atherosclerosis, particularly in diabetes: is it time to reconsider? |
| Q39002320 | Chronic Toxic Metal Exposure and Cardiovascular Disease: Mechanisms of Risk and Emerging Role of Chelation Therapy |
| Q60932241 | Construction of a Glutathione-Responsive and Silica-Based Nanocomposite for Controlled Release of Chelator Dimercaptosuccinic Acid |
| Q38585738 | EDTA Chelation Therapy to Reduce Cardiovascular Events in Persons with Diabetes |
| Q38707380 | Edetate Disodium-Based Treatment for Secondary Prevention in Post-Myocardial Infarction Patients |
| Q37257133 | Efficacy of reversal of aortic calcification by chelating agents |
| Q28387911 | Functionalized Nanoporous Silica for the Removal of Heavy Metals from Biological Systems: Adsorption and Application |
| Q26747605 | Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy |
| Q42278826 | In vitro removal of toxic heavy metals by poly(γ-glutamic acid)-coated superparamagnetic nanoparticles |
| Q28572784 | Induction of thermal and chemical stability of O6-methylguanine-DNA methyltransferase by Ca2+ |
| Q82081663 | Sodium thiosulfate prevents vascular calcifications in uremic rats |
| Q90451838 | Stable Monomeric Insulin Formulations Enabled by Supramolecular PEGylation of Insulin Analogues |
| Q38966370 | The application of EDTA in drug delivery systems: doxorubicin liposomes loaded via NH4EDTA gradient |
| Q33952145 | The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT) |
| Q34376795 | The role of chelation in the treatment of other metal poisonings |
Search more.